Inovio Pharmaceuticals
INO
#8871
Rank
HK$1.15 B
Marketcap
HK$16.81
Share price
-0.46%
Change (1 day)
-46.35%
Change (1 year)

Inovio Pharmaceuticals (INO) - Total debt

Total debt on the balance sheet as of September 2025 : HK$77.97 Million

According to Inovio Pharmaceuticals's latest financial reports the company's total debt is HK$77.97 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Inovio Pharmaceuticals - Total debt on balance sheet (from 1998 to 2025)

Total debt by year

Year Total debt Change
2024-12-31HK$92.11 M-60.96%
2023-12-31HK$0.23 B-5.85%
2022-12-31HK$0.25 B-2.68%
2021-12-31HK$0.25 B-14.94%
2020-12-31HK$0.30 B-60.94%
2019-12-31HK$0.77 B
2018-12-31N/A
2010-12-31N/A-100%
2009-12-31HK$93.93 M0.38%
2008-12-31HK$93.57 M
2003-12-31HK$2.56 M1494.59%
2002-12-31HK$0.16 M-57.1%
2001-12-31HK$0.37 M
2001-03-31HK$0.91 M-0.6%
2000-03-31HK$0.92 M18.88%
1999-03-31HK$0.77 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
HK$473.48 B 607,153.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$356.34 B 456,926.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
HK$2.74 B 3,423.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$249.17 B 319,474.46%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
HK$321.94 B 412,805.93%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$185.67 B 238,038.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
HK$194.07 B 248,807.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Cleveland BioLabs
CBLI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA